Is Alzheimer's disease a mitochondrial disorder?

被引:31
|
作者
Cash, AD [1 ]
Perry, G [1 ]
Ogawa, O [1 ]
Raina, AK [1 ]
Zhu, XW [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
Alzheimer's disease; amyloid-beta; antioxidants; free radicals; mitochondria; neurodegeneration;
D O I
10.1177/107385802236968
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cell bodies of neurons at risk of death in Alzheimer's disease (AD) have increased lipid peroxidation, nitration, free carbonyls, and nucleic acid oxidation. These oxidative changes occur in all vulnerable neurons and are reduced in neurons that contain neurofibrillary pathology. In this review, the authors provide a summary of recent work that demonstrates key abnormalities that may play a part in initiating and promoting neuronal oxidative damage. Mitochondrial abnormalities are clearly involved as a source of reactive oxygen species that culminates in perikaryal oxidative damage. However, because mitochondria in AD do not exhibit striking evidence of oxidative damage, as would be expected if they produced free radicals directly, the authors suspected that abnormal mitochondria are responsible for supplying a key reactant, that once in the cytoplasm, releases radicals. Because abnormal mitochondria, H2O2 and redox-active iron are juxtaposed in the same AD neuron, it has all the markings of a "radical factory." The proximal causes of mitochondrial abnormalities likely involve reentry into the cell cycle, where organellokinesis and proliferation results in an increase of mitochondria and intermediately differentiated cells, with a consequent increase in turnover. Supporting this, the authors have considerable in vivo and in vitro evidence for mitotic disturbances in AD.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [21] Mitochondrial Disorders in Alzheimer's Disease
    Sukhorukov, Vladimir S.
    Mudzhiri, Natalia M.
    Voronkova, Anastasia S.
    Baranich, Tatiana I.
    Glinkina, Valeria V.
    Illarioshkin, Sergey N.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (06) : 667 - 679
  • [22] Alzheimer's disease as a metabolic disorder
    Bloom, George S.
    Norambuena, Andres
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2018, 25 (04)
  • [23] Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease
    Wu, Aston J.
    Tong, Benjamin C. -K.
    Huang, Alexis S.
    Li, Min
    Cheung, King-Ho
    CURRENT ALZHEIMER RESEARCH, 2020, 17 (04) : 329 - 343
  • [24] Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer's disease
    Isaac G.Onyango
    Neural Regeneration Research, 2018, 13 (01) : 19 - 25
  • [25] Increased Mitochondrial Aldehydedehydrogenase in the putamen of individuals with Alzheimer's disease
    Michel, Tanja Maria
    Gsell, Wieland
    Kaesbauer, Ludwig
    Tatschner, Thomas
    Sheldrick, Abigail Jane
    Neuner, Irene
    Schneider, Frank
    Gruenblatt, Edna
    Riederer, Peter
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (04) : 1295 - 1301
  • [26] Current Advances in Mitochondrial Targeted Interventions in Alzheimer's Disease
    Sousa, Tiago
    Moreira, Paula I.
    Cardoso, Susana
    BIOMEDICINES, 2023, 11 (09)
  • [27] Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium
    Singulani, Monique P.
    De Paula, Vanessa J. R.
    Forlenza, Orestes, V
    NEUROSCIENCE LETTERS, 2021, 760
  • [28] Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease
    Cardoso, S. M.
    Pereira, C. F.
    Moreira, P. I.
    Arduino, D. M.
    Esteves, A. R.
    Oliveira, C. R.
    EXPERIMENTAL NEUROLOGY, 2010, 223 (02) : 294 - 298
  • [29] Metabolic disorder in Alzheimer’s disease
    Mrinal K. Poddar
    Soumyabrata Banerjee
    Apala Chakraborty
    Debasmita Dutta
    Metabolic Brain Disease, 2021, 36 : 781 - 813
  • [30] Neuronal Calcium Signaling, Mitochondrial Dysfunction, and Alzheimer's Disease
    Supnet, Charlene
    Bezprozvanny, Ilya
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S487 - S498